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Background: Antimicrobial peptides (AMPs) have the potential to act against multiple pathogenic targets.
Results: AMPs that maintain conformational flexibility are more potent against multiple pathogens and less hemolytic.
Conclusion: Antimicrobial action and hemolysis proceed via differing mechanisms.
Significance: The potency, selectivity, and ability of AMPs to reach intracellular pathogens can be modulated using general
principles.
We used a combination of fluorescence, circular dichroism
(CD), and NMR spectroscopies in conjunction with size exclu-
sion chromatography to help rationalize the relative antibacte-
rial, antiplasmodial, and cytotoxic activities of a series of pro-
line-free and proline-containing model antimicrobial peptides
(AMPs) in terms of their structural properties.When compared
with proline-free analogs, proline-containing peptides had
greater activity against Gram-negative bacteria, two mamma-
lian cancer cell lines, and intraerythrocytic Plasmodium falcip-
arum, which they were capable of killing without causing
hemolysis. In contrast, incorporation of proline did not have a
consistent effect on peptide activity against Mycobacterium
tuberculosis. In membrane-mimicking environments, struc-
tures with high -helix content were adopted by both proline-
free and proline-containing peptides. In solution, AMPs gener-
ally adopted disordered structures unless their sequences
comprisedmore hydrophobic amino acids or until coordinating
phosphate ions were added. Proline-containing peptides
resisted ordering induced by either method. The roles of the
angle subtended by positively charged amino acids and the posi-
tioning of the proline residues were also investigated. Careful
positioning of proline residues in AMP sequences is required to
enable the peptide to resist ordering andmaintain optimal anti-
bacterial activity, whereas varying the angle subtended by posi-
tively charged amino acids can attenuate hemolytic potential
albeit with a modest reduction in potency. Maintaining confor-
mational flexibility improves AMP potency and selectivity
toward bacterial, plasmodial, and cancerous cellswhile enabling
the targeting of intracellular pathogens.
Linear cationic amphipathic -helical peptides comprise a
class of molecules that often have highly potent antimicrobial
properties and consequently have attracted considerable atten-
tion in the development of therapeutic agents (1–4). A major
goal in this field is to improve the potency of the antimicrobial
peptides (AMPs)2 while reducing their toxicity to host cells.
The hydrophobicity and secondary structure of linear cati-
onic amphipathic antimicrobial peptides influence their ability
to both self-associate and insert into biological membranes.
These properties contribute both to antimicrobial potency and
host cell toxicity. Many -helical AMPs incorporate proline or
glycine residues, which may enable helical sections to be inter-
rupted, conferring conformational flexibility on the peptide.
The-helix conformation adopted bymanyAMPs in biological
membranes, which constitute either their target of action or the
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main barrier to intracellular targets (5), is now regarded as a key
determinant of activity (6). Therefore, the presence of helix-
destabilizing residues such as glycine or proline would be
expected to have a critical effect. Accordingly, a number of pre-
vious studies have found that incorporating proline residues
into AMPs decreases the ability of the peptide to permeabilize
the cytoplasmic membrane of Escherichia coli (7) with a con-
comitant reduction in the antibacterial activity (7–9). Similarly,
substituting helix-promoting residues for glycines in the pri-
mary sequence of magainin peptides improved the antimicro-
bial activity considerably, although a small increase in hemoly-
city was also detected (10).
In contrast, other studies have found that incorporating
either L- or D-proline into either the hydrophobic or hydro-
philic face of an amphipathic cationic -helix model peptide,
thus disordering the peptide secondary structure, can lead to an
improvement, rather than a reduction, in antibacterial activity
as well as a reduction in hemolycity (11, 12). This has been
ascribed to the ability of proline-containing peptides to resist
self-association and interact selectively with anionic lipids as
found in the bacterial target membranes but not in those of
erythrocytes.
Here, to reconcile these differing views of the effects of pro-
line-induced conformational flexibility on antibacterial
potency, we tested the hypothesis that the ability to maintain a
disordered structure in certain environments is crucial to AMP
potency against a range of bacterial and eukaryotic pathogens
and considered the importance of the positioning of the proline
residue. We performed a detailed study of the structure and
conformation of a series of proline-free and proline-containing
model peptides. We found that the properties conferred on
AMPs by proline residues depend strongly on the properties of
the proline-free template peptide as well as the positioning of
the proline residue in the primary sequence. Using circular
dichroism (CD) spectroscopy supported by fluorescence spec-
troscopy, size exclusion chromatography, and NMR diffusion
measurements, we show that in solution, analogously to melit-
tin (13), ordering of structure, which may be related to peptide
self-association, of model peptides can be induced through the
addition of phosphate anion at fixed pH or through increasing
the hydrophobicity of the peptides by incorporating phenylala-
nine residues at the N terminus. Proline-containing peptides
resisted this process whether induced by either phosphate
anions or increased hydrophobicity. The relationship between
the structural ordering of the peptides and their activities
against eukaryotic cell targets was notable. Proline-containing
peptidesweremore active against bothmammalian cancer cells
and the malaria parasite Plasmodium falciparum but had sub-
stantially reduced hemolytic potential and differential effects
againstMycobacterium tuberculosis.
Some small but significant differences in activity against
E. coli and Pseudomonas aeruginosa were observed within the
series of proline-containing peptides and were ascribed to the
effects of the differing positions of the proline residues. By
investigating this further, we obtained high resolution struc-
tures of three proline-containing analogs in the presence of the
anionic detergent sodium dodecyl sulfate (SDS) using NMR
spectroscopic methods. The structures reveal that the position
of the single proline in the primary sequence of the model pep-
tide has a considerable effect on the ability of the peptide to
adopt an -helix conformation in a membrane-mimicking
environment.
MATERIALS ANDMETHODS
Peptides—Peptides comprising L-amino acids (Table 1) were
purchased from either EZBiolab (Carmel, IN) or Pepceuticals
Ltd. (Nottingham, UK) as desalted grade. Peptides comprising
D-amino acids were synthesized using standard manual Fmoc
(N-(9-fluorenyl)methoxycarbonyl) solid state chemistry. HPLC
purification was performed using methanol/water or acetoni-
trile/water gradients, and the identity of the product was con-
firmed by matrix-assisted laser desorption ionization mass
spectrometry. Peptides were lyophilized from 10% acetic acid
to remove the trifluoroacetic acid counterion.
Broth Microdilution Assay—The activities of the peptides
against two strains of E. coli were assessed in planktonic sus-
pension in polypropylene 96-well plates (Greiner Bio-One,
Frickhausen, Germany) according to a modified broth dilution
assay (14). E. coli NCTC 9001, P. aeruginosa PAO1, and E. coli
TOP10were gifts fromK. D. Bruce andC. Junkes. E. coliNCTC
9001, P. aeruginosa PAO1, or competent E. coli TOP10 were
grown without shaking in 50 ml of Mueller-Hinton broth at
37 °C. Peptides were tested in duplicates with two rows allo-
cated for each peptide. In each of columns 2–11, 50l ofMuel-
ler-Hinton brothwas added under sterile conditions. In the first
row, 50 l of 256 g/ml stock peptide solutions prepared in
distilled water were added, and then the broth from the second
row was pipetted into the first row and thoroughly mixed
before being deposited again in the second row. This process
was repeated throughout the tray, providing a 2-fold dilution of
peptide with each row. Bacteria with anA620 of 0.001 were then
added to each well in volumes of 50 l, giving a further 2-fold
dilution and a final volume of 100l/well. The final columnwas
used either as sterility control (100 l of broth) or negative
control (no peptide). Plates were incubated overnight at 37 °C,
and theA620 was read. Growth curves prepared fromduplicates
were fitted to determine the peptide concentration required to
inhibit growth by 50% (MIC50). The MIC50 quoted for each
peptide (Table 2) is an average value from at least two inde-
pendent repeats.
Antituberculosis Assay—The activities of the D-amino acid
peptides against M. tuberculosis H37Ra, an attenuated M.
tuberculosis strain commonly used as a standard strain for anti-
tuberculosis drug testing, were tested in amanner similar to the
broth microdilution assay described above. Duplicate serial
dilutions from 100 to 0.78 M peptide were prepared in a total
volume of 180 l of Middlebrook 7H9 broth supplemented
with Middlebrook oleic albumin dextrose catalase growth sup-
plement in 96-well plates. A bacterial suspension (20l of a 1
106 cfu/ml suspension) was added to each well, giving a final
volume of 200 l/well. The plates were sealed and incubated at
37 °C with 5% CO2 for between 4 and 5 weeks prior to inspec-
tion. For negative and 1% growth controls, wells contained 20
l of a 1 106 or 1 104 cfu/ml suspension, respectively, and
180 l of broth.
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Antiplasmodial Assay—The activities of the peptides com-
prising D-amino acidswere tested against both the 3D7 andC10
strains of P. falciparum using fluorescent nucleic acid binding
dye assays modified from Bacon et al. (15). Ring stage parasites
maintained in AlbuMAX RPMI 1640 complete medium were
presynchronized using magnetic cell sorting and differential
lysis with sorbitol. 2-Fold serial dilutions of each peptide stock
in culture medium of concentrations between 64 and 0.064 M
were distributed into either polypropylene 96-well plates (3D7;
Greiner Bio-One) or polystyrene Nunc MicroWellTM plates
(C10) in a total volume of 50l. 150l of a thoroughlymixed P.
falciparum culture at ring stage was added into each well to a
final volume of 200l, giving final peptide concentrations rang-
ing from 16 to 0.016 M. The parasitemia was between 1.5 and
2%, whereas the final hematocrit was between 3.5 and 4%. Con-
ditions were prepared for the SYBR Green II assay in triplicate,
whereas two additional wells were used for slide preparation
with Giemsa stain and determination of parasitemia under a
light microscope. Wells containing parasite culture (1.5–2%
parasitemia, 3.5–4% final hematocrit) without peptide served
as a growth control. For time 0 controls, 50 l of fresh culture
medium and 150l of malaria culture were added to a separate
96-well plate, which was immediately stored at 20 °C. The
plates were gassed with 5% O2, 5% CO2, and 90% N2 in a sealed
gas chamber for 5 min and then incubated at 37 °C for a total of
48 h. Immediately following incubation, blood smears were
prepared from each condition, and the plates were stored at
20 °C. The assay plates as well as the time 0 plate were thawed
at room temperature for the SYBR Green assay. After mixing,
100 l of the contents of each well was transferred to black
96-well plates, and 100l of SYBRGreen II/lysis buffer solution
(0.2 l of SYBR Green II/ml of lysis buffer consisting of 20 mM
Tris, pH 7.5, 5 mM EDTA, 0.008% (w/v) saponin, and 0.08%
(v/v) Triton X-100) was added to each well. The plates were
incubated in the dark for 1 h and inspected with a FLUOstar
Omega (BMG LABTECH GmbH, Ortenberg, Germany) fluo-
rescence plate reader with excitation at 485 nm and emission
monitored at 530 nm.
Hemolysis Assay—A duplicate dilution series of peptides
from 256 to 0.016 M was prepared in 10 mM Tris, 150 mM
NaCl, pH 7.4 buffer. Fresh erythrocytes were washed thor-
oughly in Tris buffer and diluted to get a final concentration of
2.5  109/ml. 50 l of this red blood cell (RBC) suspension
was added to 450 l of the prepared peptide dilution series in
microcentrifuge tubes, giving a final RBC concentration of
2.5 108/ml. The tubes were incubated for 5min on ice, then
30 min at 37 °C, and a further 5 min on ice before being centri-
fuged (5 min at 2000  g at 4 °C). 230 l of supernatant from
each tube was transferred to a polystyrene Nunc MicroWell
plate. To generate a positive control, 230 l of a 0.1% Triton
X-100 solution was added to erythrocyte pellets prepared from
tubes challenged with 450 l of Tris buffer only. The resulting
suspensions (230 l) were transferred to the same plate, which
was read at 540 nm.The percentage of hemolysiswas calculated
relative to the positive control (100%).
3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium Bro-
mide Assay—Cytotoxicity was evaluated by performing the
3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide
(Sigma) assay (16). 10,000 adenocarcinomic human alveolar
basal epithelial cells (A549) or 10,000 RAW 264.7 Abelson
murine leukemia virus-transformed macrophages (RAW
264.7) per well were plated in 96-well plates (Costar). The cells
were incubated with peptide solutions prepared in serum-free
Opti-MEM for 4 h at 37 °C. Untreated cells were used as a
negative control. The cells were then incubated with 200 l of
prewarmed 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide solution (0.8 mg/ml) per well for a further 2 h.
The toxicities of the peptides to bothmousemonocytic macro-
phage cell line RAW 264.7 and human lung cancer cell line
A549 at different concentrations were evaluated by comparing
the absorbance of formazan crystals (dissolved using isopropa-
nol) formed by the 3-(4,5-dimethythiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide reagent at 570 nm.
Circular Dichroism—Simultaneous UV absorption and CD
spectrawere acquiredonaChirascanorChirascanPlus spectrom-
eter (Applied Photophysics, Leatherhead, UK). The instruments
were flushed with pure nitrogen gas throughout the measure-
ments. Far-UV spectrawere recorded from 260 to 185 nmwith a
1-nm spectral bandwidth, 0.5-nm step size, and 1-s spectrom-
eter time per point. A rectangular 0.5-mmpathlengthwas used.
Peptides were dissolved in 5 mM Tris-amine buffer at pH 7.2 to
a final concentration of around 20 M. Peptide samples were
also prepared in the presence of 50 mM SDS or 50% (v/v) trif-
luoroethanol. Peptide titrationwith sodiumphosphatewas car-
ried out in situ (0.5-mm pathlength) using a 1 M sodium phos-
phate (pH 7.2)-containing 20 M peptide as stock solution.
Unless otherwise stated, all spectra were measured at 37 °C.
During data processing, a spectrumof the peptide-freemedium
or solution was buffer-subtracted, and Savitsky-Golay smooth-
ing with a convolution width of 5 points was applied. CD spec-
tra were normalized for concentration and pathlength and
expressed in terms of molar ellipticity per residue. Secondary
structure analyses were performed using CDPro (17).
Tryptophan Fluorescence—Fluorescence emission spectra of
tryptophan-containing peptides were acquired using a Cary
Eclipse fluorescence spectrophotometer using an excitation
wavelength of 280 nm and scanning from 300 to 450 nm at
37 °C. Peptides were made up to a final concentration of 20 M
using 5 mM Tris buffer at pH 7.0. 900 l of a peptide solution
was titrated with small volumes of phosphate buffer in a 4 
10-mmcuvette. Next, normalized fluorescence intensities were
plotted against wavelength and fitted to a log normal distribu-
tion as described (18) inOrigin 8 (OriginLab Corp., Northamp-
ton, MA), and the wavelengths of the maximum intensities
(max) were plotted against the concentration of hydrogen
phosphate ions.
Size Exclusion Chromatography—75 l of peptide solutions
prepared in the appropriate buffer at a final concentration of 1
mg/ml was injected onto a SuperdexTM 75 10/300 GL column
(GEHealthcare). Buffers contained 10mMTris-amine, 150mM
NaCl, and sodium phosphate at varying concentrations (either
0, 50, 100, 200, or 500 mM) and were adjusted to pH 7.0. Pep-
tides were eluted at a flow rate of 0.5ml/min on anAgilent 1100
HPLC system with detection at 215 and 280 nm.
Diffusion-ordered Spectroscopy—Samples were prepared in
an analogousmanner to those used in CDmeasurements but at
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a peptide concentration of 100M (i) in 5mMTris-amine buffer
at pH7.2 and (ii) titrated to 500mMsodiumphosphate at pH7.2
with each buffer containing 5% D2O. NMR spectra were
acquired at 298 K on a Bruker Avance 500-MHz spectrometer
(Bruker, Coventry, UK) equipped with a cryoprobe. The 1H 90°
pulse lengthwas calibrated for each sample andwas found to be
close to 7.8 s for i and 15.6 s for ii. Diffusion measurements
were made using a double stimulated echo pulse program
including bipolar gradient pulses and a longitudinal eddy cur-
rent delay. The spectral width was set to 12 ppm, and the num-
ber of scans was set to 32. The relaxation delay was 1 s, and the
gradient pulse strength was increased from 5 to 95% of the
maximum gradient strength (50 gausscm1). The diffusion
time was set to 120 ms, and bipolar gradient pulses of 1.25 ms
were applied. Data were processed, and diffusion coefficients
were extracted by fitting intensities in the manufacturer’s soft-
ware (TopSpin).
NMR Structure Determination—The NMR samples con-
sisted of a 1 mM peptide solution also containing 100 mM SDS-
d25 with 5 mM Tris(hydroxymethyl-d3)-amino-d2-methane
buffer at pH 7. 10% D2O-containing trimethylsilyl propanoic
acid was added for the lock signal and as an internal chemical
shift reference. The temperature was kept constant at 310 K
during theNMRexperiments. NMR spectra were acquired on a
Bruker Avance 500-MHz spectrometer (Bruker) equippedwith
a cryoprobe. Standard Bruker total correlation spectroscopy
andNOESY pulse sequences were used with water suppression
using aWATERGATE 3-9-19 sequence with gradients (mlevg-
pph19 and noesygpph19). The 1H 90° pulse was calibrated at
37.04 kHz. The total correlation spectroscopy mixing time was
90 ms, and the mixing time for the NOESY spectra was set to
150 ms. The relaxation delay was 1 s. 2048 data points were
recorded in the direct dimension, and either 256 or 512 data
points were recorded in the indirect dimension. The spectra
were processed using Bruker TopSpin. The free induction
decay was multiplied by a shifted sine2 window function. After
Fourier transformation, the spectra were phase-corrected, a
base-line correctionwas applied, and spectra were calibrated to
the trimethylsilyl propanoic acid signal at 0 ppm.
Assignments were carried out with SPARKY software (19),
and structure calculations were done with ARIA software (20)
using NOE restraints of backbone protons and proline H pro-
tons only and no dihedral angle restraints. We chose to add the
H protons of proline to compensate for the fact that this amino
acid residue does not have an NH proton on the backbone and
because proline H atoms are easy to assign and do not overlap
with other peaks. Restraints involving the side chain atoms of
tryptophan were removed because they were violated in every
model during and after the structure calculation. The side chain
atoms of other residues were removed because the overlapping
peaks from especially lysine and leucine residues made it diffi-
cult to unambiguously assign and reliably integrate these peaks.
The ARIA software was configured to use manual assignments
and not allowed to change them. Proton frequency windows
were set to 0.02 and 0.04 for the direct and indirect dimensions,
respectively. Upper and lower bound correctionswere disabled.
Structures were calculated using torsion angle molecular
dynamics with the slow cooling protocol as published (21) fol-
lowed by refinement in water using default ARIA settings. 100
structures were calculated in each of eight iterations, and the 10
best structures were kept. Network anchoringwas enabled dur-
ing the first three iterations. Results were analyzed with AQUA
andPROCHECK_NMRsoftware (22) and python scripts devel-
oped in our laboratory. An overview of all backbone NOESY
contacts that were used in the structure calculations is available
in supplemental Table 3. Structures of LAK160-P7, LAK160-
P10, andLAK160-P12were deposited in theRCSBProteinData
Bank under accession codes 2l96, 2l99, and 2l9a, respectively.
RESULTS
Peptide Design—Peptides (Table 1) were designed to adopt
amphipathic -helix conformations in the appropriate envi-
ronments. The peptides comprise a series of alternating alanine
and leucine residues with two lysine residues located close to
each of the N and C termini. The C terminus in each peptide is
amidated, which together with the four lysines that are distrib-
uted elsewhere in the sequences anddescribe the “charge angle”
when the peptide adopts an amphipathic -helix confers a
nominal charge of9 to each peptide. We have previously dis-
cussed the importance of considering the design of peptides
where the angle subtended by the charged residues is varied
(23) and recall previous work that describes the activities of
cationic -helical peptides where the hydrophobic moment is
either balanced (24) or ignored (25) when altering the charge
angle. In the present study, we were interested in the ability of
proline residues tomodulate self-association while considering
their effects on the charge angle when adopting -helical con-
formations. Consequently, proline-free and proline-containing
peptides (Table 1)were designedwithout attempting to balance
the hydrophobic moment.
A number of previous studies (23, 26–28) have noted the
enhanced activities of peptides comprising D-amino acids when
compared with analogous peptides prepared from L-amino
acids, in particular against P. falciparum. To pursue this fur-
ther, we prepared two series of cationic amphipathic peptides
comprising all D-amino acids (supplemental Table 1 and Table
1). The first of these (supplemental Table 1; D-LAKn) was used
to identify which charge angle conferred optimal antibacterial
activity. Data obtained for the two E. coli strains, P. aeruginosa,
and M. tuberculosis (supplemental Table 2 and supplemental
Fig. 1) indicated that a charge angle of 120° conferred the most
potent antibacterial activity, and this peptidewas used as a tem-
plate for the second series (Table 1; D-LAK120, etc.). In this
series, the peptide hydrophobicity was reduced through alter-
ing the ratio of alanine to leucine residues (D-LAK120-A)
and/or incorporating histidine residues (D-LAK120-H). Proline
residues were included in place of leucine or histidine in three
peptides at position 13. The final two peptides in this series
reassessed the biological effect of varying the charge angle in a
proline-containing peptide (D-LAKn-HP13).
In light of the conflicting reports regarding the effect of pro-
line incorporation on antibacterial activity, we investigated
whether the positioning of proline would affect activity. For
reasons of cost, all L-amino acid peptides were used in this part
of the study. Three proline-free peptide templates were
selected that are defined by the charge angle, 80°, 120°, or 160°,
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subtended by the four lysine residues described above. For each
template peptide, proline residues were substituted for leucine
residues in one of three positions. The proline residues were
expected to confer conformational flexibility on the peptides
while interrupting the-helix conformation. A range of proline
locations was required so that the effects of proline location on
the conformation adopted in N- and C-terminal segments of
differing lengths could be probed.
Finally, three further peptides comprising all L-amino acids
where additions of hydrophobic phenylalanine residues were
made at the N terminus were designed. The hydrophobic phe-
nylalanine residues were included to promote peptide self-as-
sociation because in addition to electrostatic effects aromatic
effects are known to contribute to peptide aggregation and
fibrillation (29). This allows the effect of proline on self-associ-
ation driven by hydrophobicity rather than phosphate anion
concentration to be tested. Either one or two phenylalanine
residues were added to the LAK80 or LAK80-P7 sequences,
generating either LAK80-F1 or LAK80-F2 and LAK80-F2-P9
respectively.
Biological Activities of All D-Amino Acid AMPs—Based on
the initial screen of D-amino acid peptides according to their
charge angle, D-LAK120was selected as the template for a series
of peptides (Table 1) where the effects of reducing peptide
hydrophobicity and incorporating proline were probed. The
activities of these peptides against Gram-negative bacteria,M.
tuberculosisH37Ra, two strains ofP. falciparum, and twomam-
malian cancer cell lines were determined as were their hemo-
lytic potential (Table 2 and Fig. 1). All of the peptides tested
were highly potent against both E. coli and P. aeruginosa and
compare very favorably with the activities of naturally occur-
ring AMPs assayed under the same conditions (30). However,
no significant differences in activity were observed as a result of
any of the modifications. When tested against P. falciparum,
modest but significant (p 0.05) improvements in antiplasmo-
dial activity were sometimes observed in proline-containing
peptides when compared with the proline-free analog. Impor-
tantly, the antiplasmodial activities need to be compared with
the peptide concentration required to lyse 50% of red blood
cells (HC50) hemolysis data obtained for each peptide as these
reveal whether plasmodial toxicity is specific or occurs only as
collateral damage associated with infected erythrocyte lysis.
HC50 values greater than 10 times the peptide concentration
required to kill 50% of parasites or cancer cells (EC50) for anti-
plasmodial activity for either strain are highlighted in bold
(Table 2) and identify only three peptides that are capable of
specific antiplasmodial activity. Light microscopy of erythro-
cyte cultures of P. falciparum (supplemental Fig. 2) shows the
effects of one such specific peptide, D-LAK120-AP13, where a
dramatic reduction in parasitemia is effected without any
observable damage to the erythrocyte hosts. Notably, incorpo-
ration of proline in the more hydrophilic D-LAK120-A or
D-LAK120-H to give D-LAK120-AP13 or D-LAK120-HP13,
respectively, led to dramatic reductions in hemolytic potential,
whereas antiplasmodial activity was maintained or improved.
This effect was not observed for the most hydrophobic analogs
(D-LAK120/D-LAK120-P13). The incorporation of proline in a
suitably hydrophilic peptide therefore confers considerable
selectivity. Interestingly, altering the charge angle in the
D-LAKn-HP13 series also had profound effects on hemolytic
potential and hence antiplasmodial specificity. All of the pep-
tides were toxic to the two mammalian cancer cell lines at low
micromolar concentrations. However,modest increases in tox-
icity were again observed for proline-containing peptides when
compared with their proline-free analogs.
The antibacterial activity of the peptides againstM. tubercu-
losis did not follow the pattern observed for the other targets
(Fig. 1). Incorporation of proline in D-LAK120-A or D-LAK120
TABLE 1
Comparison of physical features of peptides used in this study
Hydrophobicity (H) and mean hydrophobic moment (H) are shown according to the combined consensus scale or Eisenberg scale and were calculated using the
HydroMCalc Java applet made available by Alex Tossi. All peptides contain eight lysine residues and are amidated at the C terminus, which confers a nominal charge of9
at neutral pH. D-Amino acid residues are shown in italics. Significant changes to the sequences are highlighted: histidine, phenylalanine, and proline residues are highlighted
in bold with proline also underlined.
Peptide Sequence Ha Hb Ha,c
D-LAK120 KKLALLALKKWLLALKKLALLALKK-NH2 1.26 0.05 1.28
D-LAK120-P13 KKLALLALKKWLPALKKLALLALKK-NH2 0.87 0.07 1.66
D-LAK120-A KKLALALAKKWLALAKKLALALAKK-NH2 0.02 0.08 2.28
D-LAK120-AP13 KKLALALAKKWLPLAKKLALALAKK-NH2 0.00 0.10 2.25
D-LAK120-H KKLALHALKKWLHALKKLAHLALKK-NH2 0.35 0.16 2.80
D-LAK120-HP13 KKALAHALKKWLPALKKLAHALAKK-NH2 1.07 0.17 3.81
D-LAK80-HP13 KKALAKALKHWLPALHKLAKALAKK-NH2 1.07 0.17 4.02
D-LAK160-HP13 KKALKHALAKWLPALKALAHKLAKK-NH2 1.07 0.17 3.40
LAK80 KKLAKALKLLALLWLKLAKALKKA-NH2 0.46 0.09 3.73
LAK80-P7 KKLAKAPKLLALLWLKLAKALKKA-NH2 0.05 0.11 3.46
LAK80-P10 KKLAKALKLPALLWLKLAKALKKA-NH2 0.05 0.11 3.33
LAK80-P12 KKLAKALKLLAPLWLKLAKALKKA-NH2 0.05 0.11 4.14
LAK120 KKLALALKKLALLWKKLALALKKA-NH2 0.46 0.09 3.02
LAK120-P7 KKLALAPKKLALLWKKLALALKKA-NH2 0.05 0.11 2.76
LAK120-P10 KKLALALKKPALLWKKLALALKKA-NH2 0.05 0.11 2.62
LAK120-P12 KKLALALKKLAPLWKKLALALKKA-NH2 0.05 0.11 3.43
LAK160 KKLKLALAKLALLWKALALKLKKA-NH2 0.46 0.09 2.59
LAK160-P7 KKLKLAPAKLALLWKALALKLKKA-NH2 0.05 0.11 2.34
LAK160-P10 KKLKLALAKPALLWKALALKLKKA-NH2 0.05 0.11 2.18
LAK160-P12 KKLKLALAKLAPLWKALALKLKKA-NH2 0.05 0.11 3.00
LAK80-F1 FKKLAKALKLLALLALKLAKALKKA-NH2 0.41 0.06 3.36
LAK80-F2 FFKKLAKALKLLALLALKLAKALKKA-NH2 0.78 0.04 3.55
LAK80-F2-P9 FFKKLAKAPKLLALLALKLAKALKKA-NH2 0.40 0.06 3.30
a Combined consensus scale.
b Eisenberg scale. cMean hydrophobic moment assuming formation of ideal -helix.
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TABLE 2
Comparison of MIC50, EC50, and HC50 values (M) for eight designed linear cationic peptides comprising all D-amino acids
Results are an average of two or more independently repeated experiments. HC50 values greater than 10 times the EC50 for antiplasmodial activity for either strain are
highlighted in bold. ND, not determined.
Peptide
MIC50 EC50
Hemolysis,
HC50
E. coli NCTC
9001
P. aeruginosa
PAO1
E. coli
TOP10
P. falciparum
3D7
P. falciparum
C10 A549 RAW264.7
D-LAK120 1.48 0.53 2.71 1.07 0.62 0.15 1.95 0.08 ND ND ND 4.06 1.30
D-LAK120-P13 1.54 0.97 1.42 0.41 0.58 0.18 0.88 0.08 2.18 0.41 2.44 0.43 3.80 0.34 11.66 0.03
D-LAK120-A 1.23 0.47 1.83 0.63 0.38 0.21 1.45 0.12 2.13 0.14 5.23 0.35 7.31 2.13 17.42 2.17
D-LAK120-AP13 1.08 0.62 1.22 0.19 0.29 0.09 0.88 0.06 2.36 0.10 3.11 0.57 3.42 0.16 58.61 10.41
D-LAK120-H 1.54 0.01 1.35 0.07 0.40 0.01 1.26 0.14 4.43 0.33 4.54 0.30 5.21 0.57 20.29 2.42
D-LAK120-HP13 ND ND ND ND 2.88 0.25 2.21 0.63 2.33 0.30 79.61 2.80
D-LAK80-HP13 ND ND ND ND 0.96 0.07 6.50 0.37 7.08 1.42 8.61 0.35
D-LAK160-HP13 ND ND ND ND 3.94 0.33 7.58 0.42 3.95 0.40 185.0 18.65
FIGURE 1. The ability of eight D-LAK peptides to inhibit the growth ofM. tuberculosis H37Ra is shown and compared with a positive growth control
(1 106 cfu/ml) and a 1%growth control (1 104 cfu/ml).When histidine-free peptides are compared (A), a reduction of antibacterial activity is observed
when proline is incorporated. For histidine-containing peptides (B), incorporation of proline increases antibacterial activity. Altering the angle subtended by
the lysine residues to either 80° or 160° diminishes peptide potency.
Proline Kinks in AMPs
OCTOBER 5, 2012•VOLUME 287•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 34125
 at UNIVERSITY OF HONG KONG on June 13, 2013http://www.jbc.org/Downloaded from 
caused a substantial reduction in efficacy (Fig. 1A). This con-
trasted with the substantial improvement seen for D-LAK120-
H when proline was incorporated (Fig. 1B). The resulting pep-
tide, D-LAK120-HP13, had the highest activity against M.
tuberculosis of all the peptides tested in the present study.
Altering the charge angle in the D-LAKn-HP13 series had a
detrimental effect on activity againstM. tuberculosis (Fig. 1B).
Ordering and Self-association of Peptides—CD measure-
ments of the peptides in solution or in the presence of mem-
brane-mimetic medium provide information on the average
secondary structure adopted by each peptide in each differing
environment. The conformational change in response to the
addition of phosphate buffer was observed for both all D- and all
L-amino acid peptide families dissolved in aqueous solution
(Fig. 2, A and B, and supplemental Figs. 2–4). Spectra were
recorded between 260 and 185 nm with absorbance spectra
recorded simultaneously. The phosphate anion absorbs at
shorter wavelengths to interfere with the CD signal. Hence,
with increasing phosphate concentration, data points at shorter
wavelengths are removed according to the monitored absorb-
ance. As shown previously for melittin, a membrane-lytic
-helical peptide from bee venom, phosphate or other coordi-
nating anions can promote self-association of peptides contain-
ing arginine or lysine residues by both minimizing electrostatic
repulsion and providing cross-link sites where two lysines may
simultaneously hydrogen bond with one orthophosphate
“bridging” moiety (13).
The comparison of the left-handed-helix-inducing effect of
phosphate anion on proline-free and proline-containing pep-
tides comprising D-amino acids was made by following the
development of the positive band at 220 nm, which is charac-
teristic of left-handed -helix conformation (Fig. 2, A and B).
Those peptides containing a proline residue resisted the
increase in left-handed -helix conformation that was charac-
teristic of the proline-free analogs (Fig. 2B). Furthermore, an
effect of hydrophobicity was seen with the most hydrophobic
proline-containing peptide, D-LAK120-P13, which responded
with a greater increase in -helix conformation at increasing
phosphate anion concentration when compared with the more
hydrophilic analogs. As with melittin, this increase in -helix
content may be expected to be linked to peptide self-associa-
tion. Support for this comes from measurements of intrinsic
tryptophan fluorescence performed in parallel to the CD stud-
ies (Fig. 2C) as well as size exclusion chromatography (Fig. 2D)
and diffusion-ordered spectroscopy NMR (supplemental Fig.
3). Fluorescence emission spectra, resulting from the single
tryptophan residue at position 11, were monitored following
the addition of increasing amounts of phosphate. Blue shifts
and intensity reductions in the fluorescence emission maxi-
mum were observed that are consistent with the tryptophan
residues in individual peptides moving to a more hydrophobic
environment as would be encountered in an oligomer and
encountering tryptophan residues from other peptides in the
oligomer in close proximity, leading to self-quenching (31).
FIGURE 2. Shown are circular dichroism spectra of D-LAK120-A (A) in 5 mM Tris buffer solution, pH 7. 3 titrated with increasing concentrations of phosphate
buffer at 37 °C. The changes in left-handed-helix content asmonitoredby theellipticity at 220nmare shownas a functionofphosphate concentration (B) and
comparedwith corresponding experiments performedwith a further four peptides. The shift in the tryptophan emissionmaximum (C) and the retention times
on a size exclusion column (D) were also evaluated as a function of phosphate concentration and are related to the buildup of secondary structure. Lines are to
guide the eye. deg, degrees. Error bars are the standard deviation of two independently repeated experiments.
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Peptide bonds from neighboring peptides may also contribute
weakly to the observed reduction in intensity (32). Qualita-
tively, the fluorescence data mirror the CD data with the great-
est changes in fluorescence and ellipticity at 220 nm in response
to phosphate anion occurring for the same proline-free pep-
tides and the least change observed for proline-containing pep-
tides, suggesting that these two parameters are closely linked.
To further investigate whether peptide self-association is
responsible for the observed conformational and fluorescence
emission changes, size exclusion chromatography and diffu-
sion-ordered spectroscopy NMR studies were performed in
parallel. The change in retention time on a Superdex 75 10/300
column is shown as a function of phosphate anion concentra-
tion (Fig. 2D). Larger particles eluted more rapidly, and with
increasing phosphate concentrations, proline-free peptides
were observed to elute at increasingly shorter time intervals.
This trend was more effectively resisted for proline-containing
peptides and is very similar to the effects observed using either
CD or fluorescence emission spectroscopy, suggesting that
these three techniques are reporting on the same phenomenon.
When diffusion-ordered spectroscopyNMRwas performed for
two pairs of proline-free/proline-containing peptides (supple-
mental Fig. 3), the results indicated a much better correlation
between peptide diffusion coefficients and absolute rather than
relative changes in size exclusion retention time. Taken
together, these data suggest that the changes in secondary
structure and shielding of tryptophan from an aqueous envi-
ronment are closely related to a relative change in particle size.
However, when set against the diffusion coefficients and con-
sidering the absolute retention times, it is apparent that the
particles comprising disordered proline-containing peptides
are larger than those comprising structurally ordered proline-
free peptides at lowphosphate anion concentrations.Whether
this corresponds to comprising a larger number of peptides
or reflects a less dense packing is unclear at present. None-
theless, both size exclusion chromatography and NMR dif-
fusion measurements are in agreement that the presence of
proline affects the supramolecular arrangement of the pep-
tides in solution.
All L-amino acid-containing LAK peptides dissolved in Tris/
Cl buffer adopted mostly disordered conformations, whereas
addition of phosphate anions induced either small ormore dra-
matic increases in right-handed -helix conformation content
depending on the charge angle and the presence or absence of
proline in the primary sequence. For proline-free peptides,
LAK80 (supplemental Fig. 4A) and LAK120 (supplemental Fig.
5A) in the absence of phosphate, disordered conformations
were adopted that nevertheless indicate equilibrium with an
-helix conformation with notable positive bands at190 nm.
Conformational equilibria have been demonstrated for other
linear peptides (33). Addition of phosphate anion produced a
substantial increase in -helix conformation content with the
appearance of strong negative bands at 207 and 220 nm and an
increase in the positive band intensity at 190 nm until the
effects of phosphate ion absorbance obscure this region. In con-
trast, the proline-free peptide with a greater charge angle,
LAK160 (supplemental Fig. 6A), adopted an-helix-disordered
state with much lower -helix content compared with the two
peptides designed to incorporate more acute charge angles. As
with the D-amino acid peptides, the incorporation of proline in
either the LAK80 or LAK120 sequences further reduced the
-helix content of the disordered state adopted in Tris buffer
and enabled the peptide to resist the ordering effects induced
by the addition of phosphate anions (supplemental Figs. 4
and 5). The effect of phosphate anion on the LAK160 pep-
tides (supplemental Fig. 6) reveals that, within this series,
both proline-free and proline-containing peptides resist
ordering in solution.
To further probe the relationship between structural order-
ing and the supramolecular organization of LAK peptides in
solution and to investigate the ability of proline residues to
interfere with this, further variants of LAK80 and its proline-
containing analog LAK80-P7 were studied (Fig. 3, A and B). All
of these variants, which incorporate either a further one or two
phenylalanine residues at the C terminus, adopted conforma-
tions with a similarly large -helix content in the presence of
model dimyristoyl phosphatidylcholine/dimyristoyl phos-
phatidylglycerol (75:25) membranes (Fig. 3B). In contrast, in
aqueous solution in the absence of phosphate ions, the second-
ary structure of the four analogs differed considerably (Fig. 3A).
LAK80 adopted a mostly disordered conformation, whereas
addition of first one and then two hydrophobic phenylalanine
residues to the sequence caused a more modest and then a
substantial increase, respectively, in -helix content. The abil-
ity of proline to disrupt -helix conformation induced by
hydrophobic interactions is now highlighted by the disordered
conformation adopted by LAK80-F2-P9, a peptide incorporat-
ing a single proline residue in addition to the two hydrophobic
phenylalanine residues at the N terminus.
Antibacterial Activities and the Positioning of Proline
Residues—The antibiotic activities of the peptides were tested
against two separate strains ofE. coli and one strain ofP. aerugi-
nosa (Table 3). E. coli NCTC 9001 is a type strain, whereas
TOP10 is a competent strain with a genotype similar to that of
DH10B, which is deficient in galU, galK, and galE (34). Inacti-
vation of galE perturbs the incorporation of glucose into the
O-side chain of lipopolysaccharide (LPS) and hence E. coli
TOP10 is expected to have an altered LPS structure. For each
peptide, E. coli TOP10 was more susceptible to AMP challenge
than the type strain. All of the designed peptides tested had
potent activity against the Gram-negative bacteria used in the
studywith the activities of some peptides entering the nanomo-
lar range, even for P. aeruginosa.
No significant differences in antibacterial activity were
detected between the D-amino acid peptides. Importantly, how-
ever, small but statistically significant differences in activity
could be detected between peptide analogs comprising L-amino
acids. Notably, the proline-free peptides with small or interme-
diate charge angles, LAK80 and LAK120, performed poorly
against E. coli NCTC 9001 when compared with the analog
with the larger charge angle, LAK160. Within the LAK80 and
LAK120 series, activity against E. coli NCTC 9001 was
enhanced by the incorporation of proline (p  0.05) irrespec-
tive of its position in the primary sequence. For the LAK120
series, a similar but less dramatic effect was seen when chal-
lenging E. coli TOP10, but when P. aeruginosa was chal-
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lenged, the positioning of the proline residue affected activ-
ity. In particular, the incorporation of proline in the LAK120
sequence was noted to increase activity (p  0.05) when
located at position 12 but decrease activity (p  0.05) when
located at position 10.
In contrast with LAK80 and LAK120, LAK160, the proline-
free analog with the largest charge angle, had potent antimicro-
bial activity against each of the panel of Gram-negative organ-
isms. Despite the high potency of the parent peptide,
incorporation of proline at position 12 led to a modest but sig-
nificant increase in activity against E. coli NCTC 9001 and P.
aeruginosa (p 0.05 and p 0.10, respectively). Substitution of
proline for leucine at position 7 had a less notable effect, but
performing the same substitution at position 10 led to a reduc-
tion in activity against the two strains (E. coliNCTC 9001, p
0.10; P. aeruginosa, p  0.05). This proline-containing analog,
LAK160-P10, was therefore significantly (p 0.05) less potent
than its close relation, LAK160-P12, against both E. coliNCTC
9001 and P. aeruginosa. E. coliTOP10 was againmore sensitive
to each of the peptides in this series, and no significant differ-
ences in activity could be discerned. In summary, both the size
of the charge angle and the positioning of the incorporated
proline residues affected the activity against Gram-negative
bacteria.
Because the LAK160 peptides showed little tendency to
adopt -helix-rich conformations in aqueous solution, the
structure adopted in the target membrane environment may
contribute to the significant differences in the observed anti-
bacterial activity. The ability of the LAK160 peptides to adopt
such conformations in the presence of membrane-mimicking
anionic detergent SDS (Fig. 3C) or model dimyristoyl phos-
phatidylcholine/dimyristoyl phosphatidylglycerol (75:25)
membranes (Fig. 3D) was confirmed. Micelles composed of the
anionic detergent SDS provide a simple model for bacterial
membranes, replicating the negative surface charge and hydro-
phobic/aqueous interface. In the presence of 50 mM SDS, all
four LAK160 peptides adopted conformations with a high
-helix content with the positive and negative bands at 190,
207, and 220 nm of lower intensity for the proline-containing
peptides as would be expected if these residues induced local-
ized disruption of -helix. However, the spectrum and result-
FIGURE 3. Circular dichroism spectra reveal the effect of peptide hydrophobicity and proline position on secondary structure in aqueous
solution and membrane-mimicking medium. CD spectra are shown for LAK80, LAK80-F1, LAK80-F2, and LAK80-F2-P9 in 5 mM Tris buffer solution (A)
or dimyristoyl phosphatidylcholine/dimyristoyl phosphatidylglycerol (75:25) liposomes (B) and LAK160, LAK160-P7, LAK160-P10, and LAK160-P12 in 50mM
SDS (C) or dimyristoyl phosphatidylcholine/dimyristoyl phosphatidylglycerol (75:25) liposomes (D). All spectra were recorded at 37 °C. deg, degrees.
TABLE 3
Comparison of MIC50 values (M) for 12 designed linear cationic pep-
tides
Results are an average of two ormore independently repeated experiments. ND, not
determined. Proline-free template peptides are indicated in bold.
Peptide E. coli NCTC 9001
P. aeruginosa
PAO1 E. coli TOP10
LAK80 13.05 0.13 ND ND
LAK80-P7 2.97 0.15 2.13 0.77 1.26 0.49
LAK80-P10 1.62 0.17 1.18 0.53 0.82 0.03
LAK80-P12 1.80 0.27 0.86 0.09 0.80 0.01
LAK120 2.95 0.06 4.20 0.92 1.47 0.64
LAK120-P7 0.80 0.03 4.45 0.19 0.45 0.10
LAK120-P10 0.78 0.01 9.16 1.43 0.47 0.15
LAK120-P12 0.97 0.06 2.14 0.53 0.68 0.14
LAK160 1.11 0.48 2.23 0.41 0.73 0.40
LAK160-P7 0.79 0.41 2.98 0.21 0.46 0.11
LAK160-P10 2.22 0.63 4.14 0.23 0.45 0.24
LAK160-P12 0.48 0.20 1.69 0.09 0.38 0.08
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ant CDPro analysis (supplemental Fig. 7) of one peptide,
LAK160-P10, indicated a substantially lower -helix content in
SDS but a higher content inmodelmembraneswhen compared
with the other proline-containing analogs. Because this peptide
is modestly but significantly less potent against E. coli NCTC
9001 and P. aeruginosa than the other two LAK160 proline-
containing analogs, we investigated the structural details of
these three peptides further.
NMR Structure Determination—The NMR structures of the
three proline-containing peptides (Fig. 4) confirm that the pep-
tides adopt mostly -helix conformation in the presence of 50
mM SDS with conformational flexibility induced through the
incorporation of proline. Importantly, however, the amount of
-helix conformation, the location and size of the region of
flexibility, and the apparent role of the proline residues differ
from one peptide to another within the LAK160-P series. The
backbone atoms for each of the 10 lowest energy structures
were superimposed, and it was found that the structures could
be aligned to one of two separate helical regions in each peptide
but not over the entire length. This was due to the conforma-
tional flexibility induced by the proline. The conformation
adopted by the peptides is also shown schematically (Fig. 4G)
where the number of structures adopting-helix conformation
at a given residue is used to reveal the predicted regions of high
and low secondary structure. Notably, LAK160-P10 has two
helical segments that are much smaller than those of either
FIGURE 4. Shown is the superimposition of backbone atoms in each of the 10 lowest energy structures for LAK160-P7 (A and B), LAK160-P10 (C and D), and
LAK160-P12 (E and F) fitted to either region 1 (A, C, and E) or region 2 (B, D, and F). Proline residues are shown in red. Also shown is a schematic representation
of the 10 lowest energy structureswhere residues that are-helical inmore than eight structures are shown as solid boxes, and those that are-helical in seven
or fewer structures are shown as a line (G). Proline residues are again marked in red.
Proline Kinks in AMPs
OCTOBER 5, 2012•VOLUME 287•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 34129
 at UNIVERSITY OF HONG KONG on June 13, 2013http://www.jbc.org/Downloaded from 
LAK160-P7 or LAK160-P12; this is qualitatively in agreement
with the NOESY (supplemental Fig. 8), NOE connectivities
(supplemental Fig. 9), and CD spectra (Fig. 2C).
Interestingly, regardless of the position of the proline resi-
due, all three LAK160 peptides form helices that are flexible
near the middle of the sequence, although the effect of substi-
tuting proline for leucine in these three peptides may differ.
Proline does not only act as a helix breaker; it also acts as a
helix-stabilizing residue. Proline can stabilize an-helix at its C
terminus by taking part in a helix-capping interaction (35) in
which the proline side chain caps the hydrophobic -helix, and
proline is the most water-soluble of all natural amino acid res-
idues and therefore an ideal candidate for a position at the sol-
vent-exposed -helix end (35). Both LAK160-P7 and LAK160-
P12 have two long -helix regions separated by a short, one- or
two-residue region that is predominantly unstructured. In con-
trast, for LAK160-P10, only three turns of -helix are observed:
one turn between Leu-5 and Leu-7 and two turns from Leu-17
to Leu-21. Furthermore, although residues Ala-8, Lys-9, Lys-
15, Ala-16, and Lys-22 also have a tendency to form a helical
structure as evidenced by their helical conformation in seven of
the 10 lowest energy structures, LAK160-P12 exhibits a greater
helical region running from Lys-2 to Lys-22 and is only inter-
rupted at Lys-9 and Leu-10. Hence, even if the mentioned
residues are included, LAK160-P10 is only capable of adopt-
ing a helical structure from Leu-5 to Lys-9 and from Lys-15
to Lys-22 with an unstructured region incorporating Leu-10
to Trp-14.
The prolines in LAK160-P7 and LAK160-P12 are in the
expected position for such interactions to stabilize theN termi-
nus of the-helix. Thehelix in LAK160-P12 is longer compared
with those in LAK160-P7 and LAK160-P10, which can be
explained by the cooperative nature of -helix formation.
Because the first three residues at theN terminus can only form
one hydrogen bond, a certain minimum number of amino acid
residues capable of -helix formation are needed. LAK160-P12
with proline at position 12 appears to satisfy this condition
most effectively. If a well defined -helix long axis is present,
then the angle subtended by the charge angles can bemeasured,
and the effect of proline substitution can be determined. The
region of conformational flexibility identified in each peptide
prevents identification of such an -helix long axis. However,
the structures do indicate that the amphipathic character of
each peptide is retained with lysine residues segregated on one
side of the structures (supplemental Fig. 10).
DISCUSSION
The prospects for the rational design of peptide antibiotics
will be greatly enhanced by an understanding not only of how
such peptides operate but also by how particular structural fea-
tures contribute to a given mode of action. At present, a con-
siderable body of work has focused on the interaction of cati-
onic amphipathic -helical peptides with bacterial membranes
(36). Althoughmany such peptides have been shown to disrupt
bacterial membranes that are rich in anionic lipids, still others
have been identified as having alternative modes of action,
requiring penetration within the bacteria and inhibition of a
number of processes that ultimately lead to bacterial cell death
(5). Furthermore, cationic antimicrobial peptides that have
been shown to act against bacterial membranes may have mul-
tiple modes of action against different bacteria or indeed mul-
tiple effects against the same cell. The lipid composition of bac-
terial membranes varies considerably from species to species
and has been shown to be a good predictor of the activity of
some antimicrobial peptides (37). Peptides that are able to
effectively cluster anionic lipids in the membranes of Gram-
negative bacteria are particularly potent against such organisms
(38–40). Magainin 2 does not effectively cluster anionic lipids
most likely due to a low density of positive charges, but its
membrane-disruptive behavior has been shown to depend on
membrane composition (41), and it potentially has the ability to
translocate intoGram-negative bacteria. Similarly, pleurocidin,
amore potent cationic-helical peptide againstGram-negative
bacteria thanmagainin 2 (30) with strongmembrane-disorder-
ing capabilities (42), has been reported to have the capacity to
both form membrane pores (43) and inhibit intracellular pro-
cesses (44). It is likely therefore that alterations in e.g. charge
density in a peptide sequence may not only enhance this prop-
erty at the expense of another but may also promote one mode
of action at the expense of another.
Because it remains challenging to isolate the action of a pep-
tide that ultimately leads to bacterial cell death and because a
given peptide may have multiple effects on a bacterial cell, we
are presently unable to predict how a given structural change in
a peptide will influence antibacterial efficacy and mode of
action. The aim of our work therefore was to precisely define
the effects of structural alterations in a series of antimicrobial
peptides on their biophysical properties and ultimately relate
both of these to the efficacy and mode of action of the peptide.
Here, we investigated the role of conformational flexibility con-
ferred on the peptide through incorporation of the -helix-
breaking residue proline. Proline residues in natural antimicro-
bial peptides and modified sequences define a hinged region
that is crucial for antibacterial potency and selectivity (11, 12,
45–52). In buforin II, the proline residue is proposed to operate
as a translocation factor as the primary mode of antibacterial
action for this peptide is considered to be the inhibition of
intracellular functions (53). In a recent study, we have deter-
mined that although buforin has a high affinity for nucleic acids
it adopts a low -helix content in the presence of Gram-nega-
tive innermembrane-mimicking liposomes and is considerably
less potent against such bacteria when compared with
magainin and pleurocidin peptides (30). We were interested to
see whether peptides that are designed to adopt conformations
with high -helix content but also incorporate proline residues
can function as potent antibacterial agents.
In addition to causing a localized disruption of -helix con-
formation, proline may have a number of effects on cationic
-helical antimicrobial peptide activity. These include the pre-
vention of peptide self-association (12), leading to improved
access through bacterial lipopolysaccharides to the bacterial
inner membrane (54); the perturbation of the charged segment
in the helical wheel, a key determinant of activity and selectivity
(24); and the ability to translocate across the inner membrane,
opening up intracellular modes of bactericidal action. Consist-
ent with previouswork (12), we have shown that proline has the
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ability to affect peptide supramolecular organization and that
this in turn is linked to greater potency against Gram-negative
bacteria. Related observations have been made for other anti-
microbial peptides: the cyclization of magainin and the substi-
tution of amino acids of varying hydrophobicity on model
membrane-active peptides led to reductions of antibacterial
activity that were attributed to reduced flexibility and greater
oligomerization, respectively (55, 56). Importantly, however,
we have demonstrated that the positioning of the proline resi-
due is crucial to the activity and that the structures adopted by
the peptides in the presence of anionic SDSwere defined by the
location of the proline residue because this affected not only the
location of the hinge region but also the conformation adopted
in more remote regions of the sequence.
In addition, we have shown that the disruption of peptide
structural ordering and its associated effects on supramolecular
organization in solution are also linked to the antiplasmodial
selectivity and ability to penetrate erythrocytes of all D-amino
acid peptides and influence their cytotoxic activity against
mammalian cancer cell lines. Understanding the antibacterial
mode of action of AMPs has been the focus of a large body of
work. Much less is known about how the same or related pep-
tides act against eukaryotic targets such as P. falciparum. The
present study showed that the incorporation of proline has a
dramatic effect on the hemolytic potential of AMPs but that
antiplasmodial activity is maintained. This indicates that the
mechanism of AMP-induced hemolysis is distinct from that
used to inhibit proliferation of P. falciparum. Furthermore,
because the infected erythrocyte is not lysed and the parasite is
effectively inhibited, the inference is that proline-containing
peptides such as D-LAK120-AP13 or D-LAK120-HP13 are
capable of penetrating erythrocytes to attack the intracellular
pathogen. Proline-free peptides are incapable of this, and the
observed antiplasmodial activity is difficult to separate from
erythrocyte lysis. Although incorporation of proline in AMPs
protects human erythrocytes from lysis, its presence enhances
toxicity against nucleated cancer cells, again suggesting distinct
mechanisms. The absence of cytotoxicity tests against primary
human cells precludes any evaluation of the peptides as poten-
tial anticancer agents but nevertheless suggests that this feature
may be beneficial. Related observations have shown that the
lytic activity of anticancer peptides is inhibited by heparin sul-
fate on the surface of the target cells and that smaller peptides
are better able to overcome this barrier (56, 58). Analogously,
the incorporation of proline in larger AMPs and the concomi-
tant prevention of self-association may aid their access to
tumor cell membranes and enhance cytotoxic activity. Hence,
although the extracellular barriers may differ from Gram-neg-
ative bacteria to P. falciparum and mammalian cells, the incor-
poration of proline may have a common effect in facilitating
access to the target membrane.
In conclusion, our findings suggest that the environment-de-
pendent structure adopted by antimicrobial peptides remains a
determinant of activity against and selectivity toward a range of
targets including Gram-negative bacteria, P. falciparum, and
M. tuberculosis and that themain contribution of proline hinge
regions is to modify the secondary structure and supramolecu-
lar assembly of the peptides in solution. This general feature
may facilitate access to target membranes and affect the mode
of interaction on arrival. The three-dimensional structures of
three proline-containing peptides show that significant
changes in structure and activity are determined by the posi-
tioning of proline residues and that careful consideration of
these effects is required to optimize potency against each target
pathogen.
Acknowledgments—We are grateful to Drs. K. D. Bruce and T. Spa-
senovski for assistance in setting up antibacterial testing in theMolec-
ular Microbiology Research Laboratory (Institute of Pharmaceutical
Science); the Tuberculosis Laboratory, Grantham Hospital, Hong
Kong for hosting experiments; and R. C. Hider for valuable
discussions.
REFERENCES
1. Hancock, R. E., and Sahl, H. G. (2006) Antimicrobial and host-defense
peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24,
1551–1557
2. Reddy, K. V., Yedery, R. D., and Aranha, C. (2004) Antimicrobial peptides:
premises and promises. Int. J. Antimicrob. Agents 24, 536–547
3. Marr, A. K., Gooderham, W. J., and Hancock, R. E. (2006) Antibacterial
peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin.
Pharmacol. 6, 468–472
4. Gordon, Y. J., Romanowski, E. G., andMcDermott, A. M. (2005) A review
of antimicrobial peptides and their therapeutic potential as anti-infective
drugs. Curr. Eye Res. 30, 505–515
5. Brogden, K. A. (2005) Antimicrobial peptides: pore formers or metabolic
inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238–250
6. Dathe, M., andWieprecht, T. (1999) Structural features of helical antimi-
crobial peptides: their potential tomodulate activity onmodelmembranes
and biological cells. Biochim. Biophys. Acta 1462, 71–87
7. Zhang, L., Benz, R., andHancock, R. E. (1999) Influence of proline residues
on the antibacterial and synergistic activities of -helical peptides. N-ter-
minal analogs of cecropin A: synthesis, antibacterial activity, and confor-
mational properties. Biochemistry 38, 8102–8111
8. Andreu, D., Merrifield, R. B., Steiner, H., and Boman, H. G. (1985) N-ter-
minal analogs of cecropin A: synthesis, antibacterial activity, and confor-
mational properties. Biochemistry 24, 1683–1688
9. Gazit, E., Boman, A., Boman, H. G., and Shai, Y. (1995) Interaction of the
mammalian antibacterial peptide cecropin P1 with phospholipid vesicles.
Biochemistry 34, 11479–11488
10. Chen, H. C., Brown, J. H., Morell, J. L., and Huang, C. M. (1988) Synthetic
magainin analogues with improved antimicrobial activity. FEBS Lett. 236,
462–466
11. Song, Y. M., Yang, S. T., Lim, S. S., Kim, Y., Hahm, K. S., Kim, J. I., and
Shin, S. Y. (2004) Effects of L- or D-Pro incorporation into hydrophobic
or hydrophilic face of amphipathic -helical model peptide on struc-
ture and cell selectivity. Biochem. Biophys. Res. Commun. 314,
615–621
12. Yang, S. T., Lee, J. Y., Kim, H. J., Eu, Y. J., Shin, S. Y., Hahm, K. S., and Kim,
J. I. (2006) Contribution of a central proline in model amphipathic -hel-
ical peptides to self-association, interaction with phospholipids, and anti-
microbial mode of action. FEBS J. 273, 4040–4054
13. Tatham, A. S., Hider, R. C., and Drake, A. F. (1983) The effect of counte-
rions on melittin aggregation. Biochem. J. 211, 683–686
14. Wiegand, I., Hilpert, K., andHancock, R. E. (2008) Agar and broth dilution
methods to determine the minimal inhibitory concentration (MIC) of
antimicrobial substances. Nat. Protoc. 3, 163–175
15. Bacon, D. J., Latour, C., Lucas, C., Colina, O., Ringwald, P., and Picot, S.
(2007) Comparison of a SYBR Green I-based assay with a histidine-rich
protein II enzyme-linked immunosorbent assay for in vitro antimalarial
drug efficacy testing and application to clinical isolates. Antimicrob.
Agents Chemother. 51, 1172–1178
16. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski,
Proline Kinks in AMPs
OCTOBER 5, 2012•VOLUME 287•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 34131
 at UNIVERSITY OF HONG KONG on June 13, 2013http://www.jbc.org/Downloaded from 
M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd,
M. R. (1988) Feasibility of drug screening with panels of human tumor
cell lines using a microculture tetrazolium assay. Cancer Res. 48,
589–601
17. Sreerama, N., and Woody, R. W. (2000) Estimation of protein secondary
structure from CD spectra: comparison of CONTIN, SELCON and
CDSSTR methods with an expanded reference set. Anal. Biochem. 287,
252–260
18. Ladokhin, A. S., Jayasinghe, S., and White, S. H. (2000) How to measure
and analyze tryptophan fluorescence in membranes properly, and why
bother? Anal. Biochem. 285, 235–245
19. Goddard, T. D., and Kneller, D. G. (2008) SPARKY 3, University of Cali-
fornia, San Francisco
20. Rieping, W., Habeck, M., Bardiaux, B., Bernard, A., Malliavin, T. E., and
Nilges, M. (2007) ARIA2: automated NOE assignment and data integra-
tion in NMR structure calculation. Bioinformatics 23, 381–382
21. Fossi, M., Oschkinat, H., Nilges, M., and Ball, L. J. (2005) Quantitative
study of the effects of chemical shift tolerances and rates of SA cooling on
structure calculation from automatically assigned NOE data. J. Magn.
Reson. 175, 92–102
22. Laskowski, R. A., Rullmann, J. A., MacArthur, M. W., Kaptein, R., and
Thornton, J. M. (1996) AQUA and PROCHECK-NMR: programs for
checking the quality of protein structures solved by NMR. J. Biomol. NMR
8, 477–486
23. Mason, A. J., Moussaoui, W., Abdelrahman, T., Boukhari, A., Bertani, P.,
Marquette, A., Shooshtarizaheh, P., Moulay, G., Boehm, N., Guerold, B.,
Sawers, R. J., Kichler, A., Metz-Boutigue, M. H., Candolfi, E., Prévost, G.,
and Bechinger, B. (2009) Structural determinants of antimicrobial and
antiplasmodial activity and selectivity in histidine-rich amphipathic cati-
onic peptides. J. Biol. Chem. 284, 119–133
24. Wieprecht, T., Dathe, M., Epand, R. M., Beyermann, M., Krause, E.,
Maloy, W. L., MacDonald, D. L., and Bienert, M. (1997) Influence of
the angle subtended by the positively charged helix face on the mem-
brane activity of amphipathic, antibacterial peptides. Biochemistry 36,
12869–12880
25. Jin, Y., Hammer, J., Pate, M., Zhang, Y., Zhu, F., Zmuda, E., and Blazyk, J.
(2005) Antimicrobial activities and structures of two linear cationic pep-
tide families with various amphipathic -sheet and -helical potentials.
Antimicrob. Agents Chemother. 49, 4957–4964
26. Nishikawa, M., and Ogawa, K. (2004) Occurrence of D-histidine residues
in antimicrobial poly(arginyl-histidine), conferring resistance to enzy-
matic hydrolysis. FEMS Microbiol. Lett. 239, 255–259
27. Hong, S. Y., Oh, J. E., and Lee, K. H. (1999) Effect of D-amino acid substi-
tution on the stability, the secondary structure, and the activity of mem-
brane-active peptide. Biochem. Pharmacol. 58, 1775–1780
28. Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E., Vasil, M. L., and
Hodges, R. S. (2005) Rational design of -helical antimicrobial peptides
with enhanced activities and specificity/therapeutic index. J. Biol. Chem.
280, 12316–12329
29. Bellesia, G., and Shea, J. E. (2009) What determines the structure and
stability of KFFE monomers, dimers, and protofibrils? Biophys. J. 96,
875–886
30. Lan, Y., Ye, Y., Kozlowska, J., Lam, J. K., Drake, A. F., and Mason, A. J.
(2010) Structural contributions to the intracellular targeting strategies of
antimicrobial peptides. Biochim. Biophys. Acta 1798, 1934–1943
31. Lakowicz, J. T. (1983) Principles of Fluorescence Spectroscopy, Plenum
Press, New York
32. Chen, Y., Liu, B., Yu, H. T., and Barkley, M. D. (1996) The peptide bond
quenches indole fluorescence. J. Am. Chem. Soc. 118, 9271–9278
33. Drake, A. F., Siligardi G., and Gibbons, W. A. (1988) Reassessment of the
electronic circular dichroism criteria for random coil conformations of
poly(L-lysine) and the implications for protein folding and denaturation
studies. Biophys. Chem. 31, 143–146
34. Durfee, T., Nelson, R., Baldwin, S., Plunkett, G., 3rd, Burland, V., Mau, B.,
Petrosino, J. F., Qin, X., Muzny, D. M., Ayele, M., Gibbs, R. A., Csörgo, B.,
Pósfai, G., Weinstock, G. M., and Blattner, F. R. (2008) The complete
genome sequence of Escherichia coliDH10B: insights into the biology of a
laboratory workhorse. J. Bacteriol. 190, 2597–2606
35. Aurora, R., and Rose, G. D. (1998) Helix capping. Protein Sci. 7, 21–38
36. Yeaman, M. R., and Yount, N. Y. (2003) Mechanisms of antimicrobial
peptide action and resistance. Pharmacol. Rev. 55, 27–55
37. Epand, R. M., Rotem, S., Mor, A., Berno, B., and Epand, R. F. (2008) Bac-
terial membranes as predictors of antimicrobial potency. J. Am. Chem.
Soc. 130, 14346–14352
38. Epand, R. M., and Epand, R. F. (2011) Bacterial membrane lipids in the
action of antimicrobial agents. J. Pept. Sci. 17, 298–305
39. Epand, R. F., Maloy, L., Ramamoorthy, A., and Epand, R. M. (2010) Am-
phipathic helical cationic antimicrobial peptides promote rapid formation
of crystalline states in the presence of phosphatidylglycerol: lipid cluster-
ing in anionic membranes. Biophys. J. 98, 2564–2573
40. Epand, R. F., Maloy, W. L., Ramamoorthy, A., and Epand, R. M. (2010)
Probing the “charge cluster mechanism” in amphipathic helical cationic
antimicrobial peptides. Biochemistry 49, 4076–4084
41. Gregory, S. M., Pokorny, A., and Almeida, P. F. (2009) Magainin 2 revis-
ited: a test of the quantitative model for the all-or-none permeabilization
of phospholipid vesicles. Biophys. J. 96, 116–131
42. Mason, A. J., Chotimah, I. N., Bertani, P., and Bechinger, B. (2006) A
spectroscopic study of the membrane interaction of the antimicrobial
peptide pleurocidin.Mol. Membr. Biol. 23, 185–194
43. Saint, N., Cadiou,H., Bessin, Y., andMolle, G. (2002)Antibacterial peptide
pleurocidin forms ion channels in planar lipid bilayers. Biochim. Biophys.
Acta 1564, 359–364
44. Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., and Hancock, R. E.
(2002) Sublethal concentrations of pleurocidin-derived antimicrobial
peptides inhibitmacromolecular synthesis inEscherichia coli.Antimicrob.
Agents Chemother. 46, 605–614
45. Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., and Matsuzaki, K.
(2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid
bilayers: proline as a translocation promoting factor. Biochemistry 39,
8648–8654
46. Kobayashi, S., Chikushi, A., Tougu, S., Imura, Y., Nishida, M., Yano, Y.,
and Matsuzaki, K. (2004) Membrane translocation mechanism of the an-
timicrobial peptide buforin 2. Biochemistry 43, 15610–15616
47. Park, C. B., Yi, K. S., Matsuzaki, K., Kim, M. S., and Kim, S. C. (2000)
Structure-activity analysis of buforin II, a histoneH2A-derived antimicro-
bial peptide: the proline hinge is responsible for the cell penetrating ability
of buforin II. Proc. Natl. Acad. Sci. U.S.A. 97, 8245–8250
48. Xiao, Y., Herrera, A. I., Bommineni, Y. R., Soulages, J. L., Prakash, O., and
Zhang, G. (2009) The central kink region of fowlicidin-2, an -helical host
defense peptide, is critically involved in bacterial killing and endotoxin
neutralization. J. Innate Immun. 1, 268–280
49. Kim, J. K., Lee, S. A., Shin, S., Lee, J. Y., Jeong, K.W., Nan, Y. H., Park, Y. S.,
Shin, S. Y., and Kim, Y. (2010) Structural flexibility and the positive
charges are the key factors in bacterial cell selectivity andmembrane pen-
etration of peptoid-substituted analog of piscidin 1. Biochim. Biophys.
Acta 1798, 1913–1925
50. Lee, S. A., Kim, Y. K., Lim, S. S., Zhu,W. L., Ko, H., Shin, S. Y., Hahm, K. S.,
and Kim, Y. (2007) Solution structure and cell selectivity of piscidin 1 and
its analogues. Biochemistry 46, 3653–3663
51. Pukala, T. L., Brinkworth, C. S., Carver, J. A., and Bowie, J. H. (2004)
Investigating the importance of the flexible hinge in caerin 1.1: solution
structures and activity of two synthetically modified caerin peptides. Bio-
chemistry 43, 937–944
52. Porcelli, F., Buck, B., Lee, D. K., Hallock, K. J., Ramamoorthy, A., and
Veglia, G. (2004) Structure and orientation of pardaxin determined by
NMR experiments in model membranes. J. Biol. Chem. 279,
45815–45823
53. Park, C. B., Kim, H. S., and Kim, S. C. (1998) Mechanism of action of the
antimicrobial peptide buforin II: buforin II kills microorganisms by pene-
trating the cell membrane and inhibiting cellular functions. Biochem. Bio-
phys. Res. Commun. 244, 253–257
54. Papo, N., and Shai, Y. (2003) Can we predict biological activity of antimi-
crobial peptides from their interactions with model phospholipid mem-
branes? Peptides 24, 1693–1703
55. Unger, T., Oren, Z., and Shai, Y. (2001) The effect of cyclization of
magainin 2 and melittin analogues on structure, function, and model
Proline Kinks in AMPs
34132 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 41•OCTOBER 5, 2012
 at UNIVERSITY OF HONG KONG on June 13, 2013http://www.jbc.org/Downloaded from 
membrane interactions: implication to their mode of action. Biochemistry
40, 6388–6397
56. Avrahami, D., Oren, Z., and Shai, Y. (2001) Effect of multiple aliphatic
amino acids substitutions on the structure, function, and mode of action
of diastereomeric membrane active peptides. Biochemistry 40, 12591-
12603
57. Fadnes, B., Rekdal, O., and Uhlin-Hansen, L. (2009) The anticancer activ-
ity of lytic peptides in inhibited by heparan sulphate on the surface of the
tumour cells. BMC Cancer 9, 183
58. Fadnes, B., Uhlin-Hansen, L., Lindin, I., and Rekdal, Ø. (2011) Small lytic
peptides escape the inhibitory effect of heparan sulfate on the surface of
cancer cells. BMC Cancer 11, 116
Proline Kinks in AMPs
OCTOBER 5, 2012•VOLUME 287•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 34133
 at UNIVERSITY OF HONG KONG on June 13, 2013http://www.jbc.org/Downloaded from 
Citations
 http://www.jbc.org/content/287/41/34120#otherarticles
This article has been cited by 1 HighWire-hosted articles: 
 at UNIVERSITY OF HONG KONG on June 13, 2013http://www.jbc.org/Downloaded from 
